Dynavax Technologies
DVAX
#5100
Rank
โ‚ฌ1.62 B
Marketcap
13,83ย โ‚ฌ
Share price
0.00%
Change (1 day)
14.83%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -โ‚ฌ34.82 Million

According to Dynavax Technologies 's latest financial reports the company's current earnings are โ‚ฌ0.33 Billion. In 2024 the company made an earning of โ‚ฌ33.59 Million, an increase over its 2023 earnings that were of โ‚ฌ2.13 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ34.82 Million-203.62%
2024 โ‚ฌ33.59 M1475.31%
2023 โ‚ฌ2.13 M-99.2%
2022 โ‚ฌ0.26 B238.78%
2021 โ‚ฌ79.15 M-257.89%
2020 -โ‚ฌ50.14 Million-58.58%
2019 -โ‚ฌ0.13 Billion-9.32%
2018 -โ‚ฌ0.14 Billion60.44%
2017 -โ‚ฌ83.19 Million-15.8%
2016 -โ‚ฌ98.8 Million4.22%
2015 -โ‚ฌ94.8 Million16.54%
2014 -โ‚ฌ81.35 Million37.09%
2013 -โ‚ฌ59.34 Million
2010 -โ‚ฌ42.47 Million214.85%
2009 -โ‚ฌ13.49 Million-37.33%
2008 -โ‚ฌ21.53 Million-66.07%
2007 -โ‚ฌ63.45 Million16.92%
2006 -โ‚ฌ54.27 Million170.36%
2005 -โ‚ฌ20.08 Million33.39%
2004 -โ‚ฌ15.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚ฌ6.16 B-20,481.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ9.18 B-30,455.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ0.90 B-3,084.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-โ‚ฌ1.75 Billion 5,669.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ6.86 B-22,792.40%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ12.78 B-42,392.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ7.04 B-23,381.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
โ‚ฌ0.13 B-545.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.43 B-4,836.19%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel